New contract gain

Clinical Computing PLC 12 June 2001 For Immediate Release, 12 June 2001 CLINICAL COMPUTING, PLC: CONTRACT GAIN Clinical Computing PLC and Independent Dialysis Foundation, Inc.: Agreement to Purchase Clinical Vision/Renal Vision clinical software Clinical Computing, Plc., (CCL) the international provider of clinical software solutions for the renal dialysis market, announces that its wholly-owned US subsidiary, Clinical Computing, Inc. (CCI) has signed a contract for the delivery of its Clinical Vision/Renal VisionTM software for general testing in the US with Independent Dialysis Foundation, Inc. (IDF) in Baltimore, Maryland. Clinical Vision/Renal Vision is the third generation renal software solution from Clinical Computing and is the result of a three-year development effort. Clinical Vision, like its predecessors (PROTONTM, di-PROTONTM) was developed to deliver future resistant value with technologies that are ahead of its competition. In addition to serving the renal marketplace, Clinical Vision is designed to extend into other clinical applications such as solid organ transplantation. IDF is a leading provider of End Stage Renal Disease treatments in the Baltimore area and is led by Dr. John Sadler, a nationally known Nephrologist. IDF provides hemodialysis to over 500 patients in ten facilities throughout Maryland. Tracey Mooney, CPA, Chief Financial Officer of IDF, said: 'Clinical Computing demonstrates their strength as a company through their responsiveness and by incorporating our suggestions into their go-forward strategy. Our experience with the Clinical Vision product is that it is easy to learn and user friendly.' Under the agreement, CCI will deliver its comprehensive clinical software for the renal market on multiple platforms including Windows, Web and PDAs. IDF will utilize the system to provide comprehensive charting, patient data analysis and to automate charge capture, resulting in a seamless blending of clinical vision and fiscal operations. The product was installed in the first week of May, 2001 and will be tested in a clinical setting for 60 days, commencing in June of 2001. END Press Enquiries: Clinical Computing Plc Tim Klenke, Vice President, Sales and Marketing, North America Tel: 513-651-3803 x 130 Binns & Co PR Ltd Peter Binns, James Horsman Tel: +44 (0)20 7786 9600

Companies

Calculus VCT (CLC)
UK 100

Latest directors dealings